These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33433179)

  • 1. "Quick, Grab the Naloxone": Overdose Preparedness for Ambulatory Clinics.
    Leyde S; Rife T; Kryzhanovskaya I
    Fam Pract Manag; 2021; 28(1):17-22. PubMed ID: 33433179
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distribution of naloxone to prevent death from heroin overdose. Study of opioid dependent patients' attitudes to be part of the antidote program].
    Håkansson A; Vedin A; Wallin C; Kral AH
    Lakartidningen; 2013 Jul 17-Aug 6; 110(29-31):1340-2. PubMed ID: 23980443
    [No Abstract]   [Full Text] [Related]  

  • 3. Overdose reversal.
    Spencer S
    Am J Nurs; 2015 Jan; 115(1):13. PubMed ID: 25545511
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of opioid overdose: a brief review of naloxone pharmacology and delivery.
    Hendley TM; Hersh EV; Moore PA; Stahl B; Saraghi M
    Gen Dent; 2017; 65(3):18-21. PubMed ID: 28475079
    [No Abstract]   [Full Text] [Related]  

  • 5. Take-home naloxone in Australia and beyond.
    Olsen A; Dwyer R; Lenton S
    Drug Alcohol Rev; 2018 May; 37(4):437-439. PubMed ID: 29744978
    [No Abstract]   [Full Text] [Related]  

  • 6. Naloxone (Narcan) nasal spray for opioid overdose.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
    [No Abstract]   [Full Text] [Related]  

  • 7. Take-home naloxone kits preventing overdose deaths.
    Eggertson L
    CMAJ; 2014 Jan; 186(1):17. PubMed ID: 24277710
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonprescription availability of the opioid antagonist naloxone.
    Landers A
    Am J Health Syst Pharm; 2018 Jul; 75(14):1069-1072. PubMed ID: 29789317
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing opioid overdose in pregnancy with take-home naloxone.
    Blandthorn J; Bowman E; Leung L; Bonomo Y; Dietze P
    Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):460-462. PubMed ID: 29271100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensure global access to naloxone for opioid overdose management.
    Balster RL; Walsh SL
    Addiction; 2016 Apr; 111(4):589-90. PubMed ID: 26995171
    [No Abstract]   [Full Text] [Related]  

  • 11. President's message: Food and Drug Administration approved naloxone and continued use of improvised nasal naloxone: What is a treatment advocate and educator to do?
    Morrone WR
    J Addict Dis; 2016; 35(4):339-345. PubMed ID: 27731792
    [No Abstract]   [Full Text] [Related]  

  • 12. Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.
    Davis CS; Carr D; Southwell JK; Beletsky L
    Am J Public Health; 2015 Aug; 105(8):1530-7. PubMed ID: 26066921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical issues and stakeholders matter.
    Dale O
    Addiction; 2016 Apr; 111(4):587-9. PubMed ID: 26995170
    [No Abstract]   [Full Text] [Related]  

  • 14. Why I Carry Naloxone.
    Stoecker WV
    Mo Med; 2024; 121(2):122. PubMed ID: 38694597
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenibut overdose.
    Sankary S; Canino P; Jackson J
    Am J Emerg Med; 2017 Mar; 35(3):516.e1-516.e2. PubMed ID: 27666756
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA Green-lights First Over-the-counter Naloxone Spray.
    Harris E
    JAMA; 2023 Apr; 329(16):1341. PubMed ID: 37018007
    [No Abstract]   [Full Text] [Related]  

  • 18. A 20-Year-Old Woman With Severe Opioid Toxicity.
    Solomon R
    J Emerg Nurs; 2018 Jan; 44(1):77-78. PubMed ID: 28427726
    [No Abstract]   [Full Text] [Related]  

  • 19. Another piece of the puzzle.
    Meador SA
    Acad Emerg Med; 1996 Jul; 3(7):657. PubMed ID: 8816179
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
    Klimas J; Egan M; Tobin H; Coleman N; Bury G
    BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.